Sign in

CIK 0001357874

  • Non-accelerated filer
  • Smaller reporting company

PRECISION BIOSCIENCES INC

Sign in to watch
Ticker
DTIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
May 21
Incorporated
DE
Entity type
Operating
Phone
+1 919-314-5512
Business address
302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
Open-market buys, last 90 days
$29,501
in 3 filings
Open-market sales, last 90 days
$27,505
in 1 filing, $28K under 10b5-1 plans

Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-01-06 ANSARI ABID Chief Financial Officer Exercise or conversion +17,566 $1.20 $21K 121,211
2020-01-06 ANSARI ABID Chief Financial Officer Exercise or conversion +2,634 $1.18 $3K 123,845
2020-01-06 ANSARI ABID Chief Financial Officer Exercise or conversion · Employee Stock Options (Right to Buy) −17,566 26,351
2020-01-06 ANSARI ABID Chief Financial Officer Exercise or conversion · Employee Stock Option (Right to Buy) −2,634 4,392
2019-12-19 Heery Christopher Chief Medical Officer Purchase +250 $12.09 $3K 250
2019-12-19 Heery Christopher Chief Medical Officer Purchase +2,235 $12.08 $27K 2,485
2019-11-08 Buehler Kevin Director Grant or award · Stock Option (Right to Buy) +60,776 60,776
2019-09-23 KHAZI FAYAZ CEO of Elo Life Systems Grant or award · Employee Stock Option (Right to Buy) +28,833 28,833
2019-09-23 JANTZ DEREK Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +52,651 52,651
2019-09-23 THOMSON DAVID S. Chief Operating Officer Grant or award · Employee Stock Option (Right to Buy) +30,922 30,922
2019-09-23 ANSARI ABID Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +52,818 52,818
2019-09-23 KANE MATTHEW R. President and CEO Exercise or conversion +10,000 $1.18 $12K 1,812,427
2019-09-23 KANE MATTHEW R. President and CEO Exercise or conversion · Employee Stock Option (Right to Buy) −10,000 13,422
2019-09-23 KANE MATTHEW R. President and CEO Grant or award · Employee Stock Option (Right to Buy) +262,252 262,252
2019-09-10 JANTZ DEREK Chief Scientific Officer Exercise or conversion +13,176 $1.18 $16K 3,858,346
2019-09-10 JANTZ DEREK Chief Scientific Officer Exercise or conversion · Employee Stock Option (Right to Buy) −13,176 10,246
2019-07-04 Scimeca Dario General Counsel Grant or award · Stock Option (Right to Buy) +160,000 160,000
2019-06-10 ANSARI ABID Chief Financial Officer Exercise or conversion +96,618 $1.20 $116K 96,618
2019-06-10 ANSARI ABID Chief Financial Officer Exercise or conversion +7,027 $1.18 $8K 103,645
2019-06-10 ANSARI ABID Chief Financial Officer Exercise or conversion · Employee Stock Option (Right to Buy) −96,618 43,917

Page 26 of 28 · 549 trades